Awni Musharbash

Amman, AM, Jordan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Radiation-induced Lymphopenia in Pediatric Medulloblastoma: A Predictor of Outcomes in a Middle-income Country?

Radiation-induced Lymphopenia in Pediatric Medulloblastoma: A Predictor of Outcomes in a Middle-income Country?

Journal: Journal of pediatric hematology/oncology

Published: January 04, 2026

Urgent Chemotherapy for Swift Symptom Relief in Patients With Medulloblastoma.

Urgent Chemotherapy for Swift Symptom Relief in Patients With Medulloblastoma.

Journal: Pediatric blood & cancer

Published: March 25, 2025

Epidemiology and Outcome of Primary Central Nervous System Tumors Treated at King Hussein Cancer Center.

Epidemiology and Outcome of Primary Central Nervous System Tumors Treated at King Hussein Cancer Center.

Journal: Cancers

Published: November 27, 2024

BRAF/MEK inhibitors use to treat ventriculoperitoneal shunt-associated ascites in pediatric low-grade gliomas.

BRAF/MEK inhibitors use to treat ventriculoperitoneal shunt-associated ascites in pediatric low-grade gliomas.

Journal: Pediatric blood & cancer

Published: April 18, 2024

BRAF/MEK inhibitors use for pediatric gliomas; real world experience from a resource-limited country.

BRAF/MEK inhibitors use for pediatric gliomas; real world experience from a resource-limited country.

Journal: Frontiers in oncology

Published: April 15, 2024

Next-generation sequencing for pediatric CNS tumors: does it add value in a middle-income country setup?

Next-generation sequencing for pediatric CNS tumors: does it add value in a middle-income country setup?

Journal: Frontiers in oncology

Published: October 27, 2023

Feasibility of treating pediatric intracranial germ cell tumors in a middle-income country: The Jordanian experience.

Feasibility of treating pediatric intracranial germ cell tumors in a middle-income country: The Jordanian experience.

Journal: Pediatric blood & cancer

Published: May 25, 2022

Molecular Subgroup Is the Strongest Predictor of Medulloblastoma Outcome in a Resource-Limited Country.

Molecular Subgroup Is the Strongest Predictor of Medulloblastoma Outcome in a Resource-Limited Country.

Journal: JCO global oncology

Published: October 05, 2021

Molecular correlates of cerebellar mutism syndrome in medulloblastoma.

Molecular correlates of cerebellar mutism syndrome in medulloblastoma.

Journal: Neuro-oncology

Published: September 11, 2019

SIOP PODC-adapted treatment guidelines for craniopharyngioma in low- and middle-income settings.

SIOP PODC-adapted treatment guidelines for craniopharyngioma in low- and middle-income settings.

Journal: Pediatric blood & cancer

Published: June 10, 2019

Video-Teleconferencing in Pediatric Neuro-Oncology: Ten Years of Experience.

Video-Teleconferencing in Pediatric Neuro-Oncology: Ten Years of Experience.

Journal: Journal of global oncology

Published: September 23, 2018

Sustained Response to Targeted Therapy in a Patient With Disseminated Anaplastic Pleomorphic Xanthoastrocytoma.

Sustained Response to Targeted Therapy in a Patient With Disseminated Anaplastic Pleomorphic Xanthoastrocytoma.

Journal: Journal of pediatric hematology/oncology

Published: December 05, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026